Metropolitan Life Insurance Company (MetLife)’s Tricida, Inc. Common Stock TCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,048
Closed -$21.5K 2378
2022
Q3
$21.5K Hold
2,048
﹤0.01% 1994
2022
Q2
$19.8K Buy
+2,048
New +$19.5K ﹤0.01% 2056
2020
Q4
Sell
-8,970
Closed -$81.3K 2586
2020
Q3
$81.3K Hold
8,970
﹤0.01% 2340
2020
Q2
$246K Buy
8,970
+1,547
+21% +$42.1K ﹤0.01% 1665
2020
Q1
$163K Hold
7,423
﹤0.01% 1708
2019
Q4
$280K Hold
7,423
﹤0.01% 1686
2019
Q3
$229K Buy
7,423
+1,160
+19% +$38.9K ﹤0.01% 1787
2019
Q2
$247K Buy
6,263
+317
+5% +$11.1K ﹤0.01% 1755
2019
Q1
$230K Hold
5,946
﹤0.01% 1809
2018
Q4
$140K Hold
5,946
﹤0.01% 2057
2018
Q3
$182K Buy
+5,946
New +$174K ﹤0.01% 2068

Other funds holding TCDA

Metropolitan Life Insurance Company (MetLife)'s TCDA Position: Q4 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Tricida, Inc. Common Stock (TCDA) in Q4 2022, closing a stake of 2,048 shares — an estimated $21.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TCDA in Q3 2018 and held it in 11 quarters. The position peaked at $280K in Q4 2019. 70 funds tracked by Wall St. Rank hold TCDA as of Q4 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Tricida, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,048 Tricida, Inc. Common Stock shares in Q4 2022, an estimated $21.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Tricida, Inc. Common Stock in Q3 2018 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Tricida, Inc. Common Stock position peaked at $280K in Q4 2019.
  • 70 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q4 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.